Cited by 87Psychedelics and Drug StudiesForensic Toxicology and Drug AnalysisSubstance Abuse Treatment and Outcomes

The neuropsychology of ecstasy (MDMA) use: a quantitative review.

Zakzanis, Konstantine K., Campbell, Zachariah, Jovanovski, Diana·2007·Human Psychopharmacology: Clinical and Experimental

Abstract

A growing number of empirical studies have found varying neuropsychological impairments associated with use of 3,4-methylenedioxymethamphetamine (MDMA) use. We set out to determine to what extent neuropsychological abilities are impaired in MDMA users. To do so, meta-analytical methods were used to determine the magnitude of neuropsychological impairment in MDMA users across pre-specified cognitive domains. We found that cognitive impairment secondary to recreational drug use may result in what might be described as small-to-medium effects across all cognitive domains with learning and memory being most impaired. We also found that total lifetime ingestion of MDMA appears to be negatively associated with performance on tasks ranging from attention and concentration to learning and memory. Implications and limitations of these findings are discussed.

Integrity signals

Registry

Crossref · 10.1002/hup.873

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zakzanis, K. K., Campbell, Z., & Jovanovski, D.
Affiliations
University of Toronto (CA)
Corresponding author
Zakzanis, Konstantine K.
Venue
Human Psychopharmacology: Clinical and Experimental
Publisher
Wiley
Published
2007-09-25
Volume
22
Issue
7
Pages
427-435
ISSN
  • 0885-6222 (ISSN-L)
  • 1099-1077
OpenAlex
W2000906264
Cited by
87
References
73
Citations by year
2025: 2 · 2024: 3 · 2022: 4 · 2021: 2 · 2020: 1 · 2019: 1 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 8 · 2013: 4 · 2012: 11
FWCI
1.76
Type
journal article
Language
en
Open access
closed
Locations
  • Human Psychopharmacology Clinical and Experimental (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
MDMA, ecstasy, neuropsychological deficits, cognitive impairment, recreational drug use, learning and memory, attention and concentration, cognitive domain
MeSH terms
Attention, Cognition Disorders, Hallucinogens, Humans, Learning, Memory, Neuropsychological Tests, Psychomotor Performance, N-Methyl-3,4-methylenedioxyamphetamine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review